July 15, 2026DrugsFDA
Gasco Industrial Corp. recalls Gasco Isopropyl Alcohol 70%, Net Contents: 1 US Gallon (3.78 L), Manufactured by: Gasco Industrial Corp., PO Box 1360, G
Hazard: Subpotent drug
July 15, 2026DrugsFDA
Gasco Industrial Corp. recalls Gasco Isopropyl Alcohol 70%, Net Contents: 16 Oz. (474 mL). Manufactured by: Gasco Industrial Corp., PO Box 1360 Gurabo
Hazard: Subpotent drug
July 15, 2026DrugsFDA
QuVa Pharma, Inc. recalls Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park On
Hazard: Failed Impurities/Degradation Specifications
July 15, 2026DrugsFDA
BioMed Laboratories, LLC. recalls Medline Remedy Specialized Silicone Cream (Hydraguard-D ),Manufactured for Medline Industries, LP, Three Lakes Drive, No
Hazard: Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification.
July 15, 2026DrugsFDA
ONESOURCE SPECIALTY PHARMA LIMITED recalls Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma
Hazard: Failed Impurities/Degradation Specifications
July 8, 2026DrugsFDA
Lupin Pharmaceuticals Inc. recalls Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe
Hazard: CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
July 8, 2026DrugsFDA
McKesson recalls Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Man
Hazard: Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.
July 8, 2026DrugsFDA
Blaine Labs Inc recalls Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl OZ (16 mL) bottle, l
Hazard: CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated
July 8, 2026DrugsFDA
Blaine Labs Inc recalls Fungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit. Contains, 1x2 oz bottle Fungal Fusion Antifungal (Mi
Hazard: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
July 8, 2026DrugsFDA
Blaine Labs Inc recalls TERPENICOL Antifungal Solution, (Undecylenic (10-Undecenoic) acid 25%), 1.0 Fl Oz (29.6 mL), Manufactured By: Blaine Lab
Hazard: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
July 8, 2026DrugsFDA
Blaine Labs Inc recalls vite20 Antifungal Cream, (10% Undecylenic Acid), 0.54 OZ (15 g) bottle, Manufactured By: Blaine Labs, Inc., 11037 Lockpo
Hazard: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
July 8, 2026DrugsFDA
Blaine Labs Inc recalls TERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz (28 g) bottles, Manufactured By: Blaine Labs, Inc., 11037 Loc
Hazard: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
July 8, 2026DrugsFDA
Blaine Labs Inc recalls TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma
Hazard: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
July 8, 2026DrugsFDA
Blaine Labs Inc recalls TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy ca
Hazard: CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
July 8, 2026DrugsFDA
Blaine Labs Inc recalls Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, packaged in 1.0 FL OZ (37 mL) bottle, shorter twist cap, Manufact
Hazard: Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp
July 8, 2026DrugsFDA
Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India;
Hazard: cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
July 8, 2026DrugsFDA
Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India;
Hazard: cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
July 8, 2026DrugsFDA
Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India;
Hazard: cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
July 8, 2026DrugsFDA
Lannett Company Inc. recalls Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Exten
Hazard: Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
July 8, 2026DrugsFDA
Asclemed USA Inc. recalls Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals,
Hazard: Lack of Assurance of Sterility
July 8, 2026DrugsFDA
Asclemed USA Inc. recalls Accucaine, Kit contains: Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by En
Hazard: Lack of Assurance of Sterility
July 8, 2026DrugsFDA
Boehringer Ingelheim Pharmaceuticals, Inc. recalls Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per B
Hazard: CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.
July 8, 2026DrugsFDA
ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, In
Hazard: Subpotent Drug
July 8, 2026DrugsFDA
Lupin Pharmaceuticals Inc. recalls prednisoLONE Acetate Ophthalmic Suspension, USP, 1%, Rx only, Sterile, a) 5 mL (NDC 70748-332-02); b) 10 mL (NDC 70748-3
Hazard: Presence of Foreign Substance
July 8, 2026DrugsFDA
SUN PHARMACEUTICAL INDUSTRIES INC recalls Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories,
Hazard: Failed Impurities/Degradation Specifications
July 8, 2026DrugsFDA
ACCORD BIOPHARMA INC recalls IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPhar
Hazard: Lack of assurance of Sterility:
July 8, 2026DrugsFDA
CareFusion 213, LLC recalls BD ChloraPrep CLear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol) 100 x 10.5 mL Applicators/case
Hazard: Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
July 8, 2026DrugsFDA
CareFusion 213, LLC recalls BD ChloraPrep CLear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol),500 x 1 mL applicators/case,
Hazard: Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
July 8, 2026DrugsFDA
CareFusion 213, LLC recalls BD ChloraPrep Scrub Teal, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol) packaged as a) 25 x 26 mL
Hazard: Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
July 8, 2026DrugsFDA
CareFusion 213, LLC recalls BD ChloraPrep Scrub Teal, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol) packaged as a) 100 x 10.5
Hazard: Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel